Acrivon Therapeutics
ACRV
#7853
Rank
HK$1.67 B
Marketcap
HK$54.16
Share price
-12.12%
Change (1 day)
33.66%
Change (1 year)

Market capitalization of Acrivon Therapeutics (ACRV)

Market cap: HK$1.67 Billion

As of November 2024 Acrivon Therapeutics has a market cap of HK$1.67 Billion. This makes Acrivon Therapeutics the world's 7853th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acrivon Therapeutics from 2022 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$1.67 B96.69%
2023HK$0.85 B-54.63%
2022HK$1.87 B

End of Day market cap according to different sources

On Nov 15th, 2024 the market cap of Acrivon Therapeutics was reported to be:

HK$1.67 Billion
by Nasdaq info icon info icon
HK$1.67 Billion
by CompaniesMarketCap info icon info icon